CD274 and mesenchymal cell neoplasm: This enrichment of immune target expression in mesenchymal tumors corroborated other work in our group in lung cancer where lung adenocarcinomas with a high lung cell line EMT score had high expression of PD-L1, which is a target of miR-200, which is also a suppressor of EMT and metastasis [20].